1.Noel, GJ, Kreiswirth, BN, Edelson, PJ, et al. Multiple methicillin-resistant Staphylococcus aureus strains as a cause for a single outbreak of severe disease in hospitalized neonates. Pediatr Infect Dis J 1992; 11:184–188.
2.Campbell, JR, Zaccaria, E, Mason, EO, Baker, CJ. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998; 19:924–928.
3.Haley, RW, Cushion, NB, Tenover, FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995; 171:614–624.
4.Andersen, BM, Lindemann, R, Bergh, K, et al. Spread of methicillin-resistant Staphylococcus aureus in a neonatal intensive unit associated with understaffing, overcrowding and mixing of patients. J Hosp Infect 2002;50:18–24.
5.Saiman, L, Cronquist, A, Wu, F, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003; 24:317–321.
6.Nambiar, S, Herwaldt, LA, Singh, N. Outbreak of invasive disease caused by methicillin-resistant Staphylococcus aureus in neonates and prevalence in the neonatal intensive care unit. Pediatr Crit Care Med 2003; 4:220–226.
7.Hitomi, S, Kubota, M, Mori, N, et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by un-selective use of nasal mupirocin ointment. J Hosp Infect 2000; 46:123–129.
8.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362–386.
9.Centers for Disease Control and Prevention. MRSA among ICU patients, 1995 — 2004. In: Healthcare—associated methicillin resistant Staphylococcus aureus (MRSA): data and statistics. Available at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_data.html. Accessed January 30, 2006.
10.Arnold, MS, Dempsey, JM, Fishman, M, McAuley, PJ, Tibert, C, Vallande, NC. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 2002; 23:69–76.
11.Herold, BC, Immergluck, LC, Maranan, MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593–598.
12.Hussain, FM, Boyle-Vavra, S, Daum, RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis 2001; 20:763–767.
13.Sattler, CA, Mason, EO, Kaplan, SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis 2002; 21:910–916.
14.Ellis, MW, Hospenthal, DR, Dooley, DP, Gray, PJ, Murray, CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39:971979.
15.Baggett, HC, Hennessy, TW, Rudolph, K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxic pantonvalentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189:1565–1573.
16.Centers for Disease Control and Prevention. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin lesions—Los Angeles County, California 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52:88.
17.Carleton, HA, Diep, BA, Charlebois, ED, Sensabaugh, GF, Perdreau-Remington, F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004; 190:1730–1738.
18.Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders—Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004; 53:767–770.
19.Healy, MC, Hulten, KG, Palazzi, DL, Campbell, JR, Baker, CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39:1460–1466.
20.Eckhardt, C, Halvosa, JS, Ray, SM, Blumberg, HM. Transmission of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit from a patient with community-acquired disease. Infect Control Hosp Epidemiol 2003; 24:460–461.
21.Hartstein, AI, LeMonte, AM, Iwamoto, PKL. DNA typing and control of methicillin-resistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol 1997; 18:42–48.
22.Villari, P, Iacuzio, L, Torre, I, Scarcella, A. Molecular epidemiology as an effective tool in the surveillance of infections in the neonatal intensive care unit. J Infect 1998; 37:274–281.
23.Mitsuda, T, Arai, K, Fujita, S, Yokota, S. Epidemiological analysis of strains of methicillin-resistant Staphylococcus aureus (MRSA) infection in the nursery; prognosis of MRSA carrier infants. J Hosp Infect 1995; 31:123–134.
24.Gavin, PJ, Paule, SM, Fisher, AG, et al. The role of molecular typing in the epidemiologic investigation and control of nosocomial infections. Pathol Case Rev 2003; 8:163–171.
25.Loureiro, MM, de Moraes, BA, Quadra, MRR, Pinheiro, GS, Suffys, PN, Asensi, MD. Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from newborns in a hospital in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2000; 95:777–782.
26.Singh, K, Gavin, PJ, Vescio, T, et al. Microbiologic surveillance using nasal cultures alone is sufficient for detection of methicillin-resistant Staphylococcus aureus isolates in neonates. J Clin Microbiol 2003; 41:2755–2757.
27.Bures, S, Fishbain, JT, Uyehara, CFT, Parker, JM, Berg, BW. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 2000; 28:465–470.
28.Vicca, AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999; 43:109–113.
29.Shiomori, T, Miyamoto, H, Makishima, K, et al. Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect 2002; 50:30–35.
30.Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126–132.
31.Herwaldt, LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999; 106(5A):11S–18S.
32.Boyce, JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Inject 2001; 48(Supplement A):S9–S14.
33.Boyce, JM, Pittet, D, Healthcare Infection COntrol Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in healthcare settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51(RR-16):1–45.
34.Humphreys, H, Duckworth, G. Methicillin-resistant Staphylococcus aureus (MRSA)—a re-appraisal of control measures in the light of changing circumstances. J Hosp Infect 1997; 36:167–170.
35.Grundmann, H, Hori, S, Winter, B, Tami, A, Austin, DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002; 185: 481–488.
36.Watanakunakorn, C, Axelson, C, Bota, B, Stahl, C. Mupirocin ointment with and without Chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect Control 1995; 23:306–309.
37.Fitzpatrick, F, Murphy, OM, Brady, A, Prout, S, Fenelon, LE. A purpose built MRSA cohort unit. J Hosp Infect 2000; 46:271–279.
38.Girou, E, Pujade, G, Legrand, P, Cizeau, F, Brun-Buisson, C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543–550.
39.Hudson, IRB. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994; 27:81–98.
40.Kotilainen, P, Routamaa, M, Peltonen, R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169–175.
41.Fujimura, S, Kato, S, Hashimoto, M, Takeda, H, Maki, F, Watanabe, A. Survey of methicillin-resistant Staphylococcus aureus from neonates and the environment in the NICU. J Infect Chemother 2004; 10:131–132.
42.Behari, P, Englund, J, Alcasid, G, Garcia-Houchins, S, Weber, SG. Transmission of methicillin-resistant Staphylococcus aureus to preterm infants through breast milk. Infect Control Hosp Epidemiol 2004; 25:778–780.